News Announcement

Dipna Pharmachem: Board Meeting Outcome for Submission Of Outcome Of Board Meeting And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors in their meeting held today i.e. 11th October 2024 at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad - 380 055 which commenced at 5:30 P. M. and concluded at 7:00 P.M. inter-alia has considered and approved appointment of Mr. Nirav Soni (DIN: 08317653) as Additional Non-Executive and Non-Independent Director of the Company w.e.f. 11th October 2024.The details required under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 09/09/2015 and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated 11/07/2023 are given in Annexure A.Kindly take the same on your record and oblige us.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.